Vericel (VCEL) Reports Q2 Loss of $0.12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Vericel Corporation (VCEL) PT Lowered to $14 at Needham & Company, Keeps 'Buy'
August 7, 2018 9:14 AM EDTNeedham & Company lowered its price target on Vericel Corporation (NASDAQ: VCEL) to $14.00 (from $15.00) while maintaining a Buy rating.
Analyst Chad Messer commented, "Vericel reported $19.0M in net product sales including $14.1M in MACI sales and $4.9M for Epicel. Our estimate was... More



